PNC Financial Services Group’s Aura Biosciences AURA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$589 Hold
83
﹤0.01% 4954
2026
Q1
$555 Buy
83
+35
+73% +$201 ﹤0.01% 4891
2025
Q4
$262 Sell
48
-305
-86% -$1.81K ﹤0.01% 4947
2025
Q3
$2.18K Buy
353
+212
+150% +$1.39K ﹤0.01% 4476
2025
Q2
$883 Buy
+141
New +$825 ﹤0.01% 4582

Other funds holding AURA

PNC Financial Services Group's AURA Position: Q2 2026 in Review

PNC Financial Services Group held its Aura Biosciences (AURA) position steady in Q2 2026 at 83 shares worth $589. The position accounts for ﹤0.01% of the portfolio, ranked #4954.

PNC Financial Services Group first reported a position in AURA in Q2 2025 and has held it in 5 quarters since. The position peaked at $2.18K in Q3 2025. 40 funds tracked by Wall St. Rank hold AURA as of Q2 2026.

  • PNC Financial Services Group held 83 shares of Aura Biosciences worth $589 as of Q2 2026.
  • PNC Financial Services Group left its Aura Biosciences share count unchanged in Q2 2026.
  • Aura Biosciences made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #4954 holding.
  • PNC Financial Services Group first reported a position in Aura Biosciences in Q2 2025 and has held it in 5 quarters since.
  • PNC Financial Services Group's Aura Biosciences position peaked at $2.18K in Q3 2025.
  • 40 funds tracked by Wall St. Rank held Aura Biosciences as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.